Group One Trading, L.P. Nymox Pharmaceutical Corp Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.19 - $0.49 $12 - $32	67 Added 1.28%	5,307 $1,000
Q1 2023 May 12, 2023	BUY	$0.33 - $0.5 $99 - $150	300 Added 6.07%	5,240 $1,000
Q4 2022 Feb 09, 2023	SELL	$0.28 - $0.74 $282 - $747	-1,010 Reduced 16.97%	4,940 $1,000
Q3 2022 Nov 09, 2022	BUY	$0.22 - $0.61 $1,309 - $3,629	5,950 New	5,950 $3,000
Q2 2022 Aug 11, 2022	SELL	$0.38 - $1.41 $13,710 - $50,872	-36,080 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.21 - $2.0 $42,935 - $70,968	35,484 Added 5953.69%	36,080 $45,000
Q4 2021 Feb 11, 2022	SELL	$0.95 - $2.1 $20,361 - $45,009	-21,433 Reduced 97.29%	596 $1,000
Q3 2021 Nov 12, 2021	BUY	$1.3 - $2.23 $23,527 - $40,358	18,098 Added 460.39%	22,029 $45,000
Q2 2021 Aug 10, 2021	BUY	$1.46 - $2.48 $4,234 - $7,192	2,900 Added 281.28%	3,931 $6,000
Q1 2021 May 12, 2021	BUY	$2.22 - $3.39 $2,242 - $3,423	1,010 Added 4809.52%	1,031 $2,000
Q4 2020 Feb 10, 2021	SELL	$1.84 - $2.83 $1 - $2	-1 Reduced 4.55%	21 $0
Q3 2020 Nov 12, 2020	SELL	$2.3 - $3.66 $1,380 - $2,196	-600 Reduced 96.46%	22 $0
Q2 2020 Aug 13, 2020	SELL	$2.1 - $4.6 $10,500 - $23,000	-5,000 Reduced 88.94%	622 $2,000
Q1 2020 May 13, 2020	BUY	$1.69 - $3.88 $7,005 - $16,082	4,145 Added 280.64%	5,622 $13,000
Q4 2019 Feb 10, 2020	BUY	$1.73 - $2.42 $2,422 - $3,388	1,400 Added 1818.18%	1,477 $3,000
Q3 2019 Nov 12, 2019	BUY	$1.41 - $2.12 $108 - $163	77 New	77 $0
Q4 2018 Feb 06, 2019	SELL	$1.31 - $2.53 $13,371 - $25,823	-10,207 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$2.46 - $3.7 $7,872 - $11,840	-3,200 Reduced 23.87%	10,207 $25,000
Q2 2018 Aug 14, 2018	SELL	$3.12 - $4.33 $118,528 - $164,496	-37,990 Reduced 73.91%	13,407 $45,000
Q1 2018 May 11, 2018	SELL	$3.09 - $4.43 $117,342 - $168,229	-37,975 Reduced 42.49%	51,397 $217,000
Q4 2017 Feb 09, 2018	BUY	$3.29 - $4.06 $74,998 - $92,551	22,796 Added 34.24%	89,372 $295,000
Q3 2017 Nov 15, 2017	BUY	$3.36 - $4.02 $160,100 - $191,548	47,649 Added 251.75%	66,576 $254,000
Q2 2017 Aug 14, 2017	BUY	N/A	18,927	18,927 $83,000

Others Institutions Holding NYMX

# of Institutions

Shares Held

150K

Call Options Held

Put Options Held

View Full List

About NYMOX PHARMACEUTICAL CORP

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

More about NYMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account